FDA Announces Joint Meeting of Psychopharmacologic Drugs and Drug Safety Committees

Summary

The US Food and Drug Administration (FDA) has scheduled a joint meeting of the Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee to discuss various pharmaceutical-related topics.